Yield10 Bioscience (NASDAQ:YTEN) issued its earnings results on Tuesday. The specialty chemicals company reported ($0.16) EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.16), Fidelity Earnings reports. Yield10 Bioscience had a negative net margin of 995.38% and a negative return on equity of 146.19%. The firm had revenue of $0.22 million during the quarter.
Shares of YTEN stock traded down $0.12 during trading hours on Friday, hitting $0.15. 269,013 shares of the company were exchanged, compared to its average volume of 171,354. The business has a 50 day moving average of $0.51 and a two-hundred day moving average of $0.79. The company has a current ratio of 3.33, a quick ratio of 3.33 and a debt-to-equity ratio of 1.17. Yield10 Bioscience has a 52 week low of $0.25 and a 52 week high of $1.77. The company has a market capitalization of $4.13 million, a PE ratio of -0.16 and a beta of 3.15.
Several equities research analysts have commented on the stock. Aegis reaffirmed a “buy” rating and issued a $2.00 target price on shares of Yield10 Bioscience in a research note on Tuesday, August 13th. National Securities reissued a “buy” rating and set a $5.00 price objective on shares of Yield10 Bioscience in a research report on Tuesday, August 20th. Finally, Zacks Investment Research reissued a “hold” rating on shares of Yield10 Bioscience in a research report on Saturday, October 19th.
Yield10 Bioscience, Inc, an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield.
Further Reading: Support Level
Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.